lamivudine - CISMeF

Preferred Label : lamivudine;

MeSH definition : A reverse transcriptase inhibitor and ZALCITABINE analog in which a sulfur atom replaces the 3' carbon of the pentose ring. It is used to treat HIV disease.;

MeSH synonym : 2',3'-dideoxy-3'-thiacytidine; 2',3' dideoxy 3' thiacytidine; 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-; 3TC Lamivudine; Lamivudine, 3TC;

CISMeF synonym : 2(1h)-pyrimidinone, 4-amino-1-(2-(h6ydroxymethyl)-1,3-oxathiolan-5-yl); 3tc;

MeSH hyponym : lamivudine, (2S-cis)-Isomer; epivir; GR-109714X; GR109714X; GR 109714X;

Related MeSH term : BCH-189; BCH 189; BCH189;

MeSH CAS label : 2(1H)-Pyrimidinone, 4-amino-1-(2-(hydroxymethyl)-1,3-oxathiolan-5-yl)-, (2R-cis)-;

MeSH Related Number : lamivudine, (2S-cis)-Isomer; 134678-17-4 (Lamivudine); 134680-32-3 ((2S-cis)-isomer); 77ANF82R6X; H6S9D88T3D;

Registry Number MeSH : 134678-17-4;

Related CAS MeSH : 134680-32-3 (Lamivudine, (2S-cis)-Isomer);

Wikipedia link : https://en.wikipedia.org/wiki/Lamivudine;

Is substance : O;

UNII : 2T8Q726O95;

InChIKey : JTEGQNOMFQHVDC-NKWVEPMBSA-N;

Details

Origin ID

D019259;

UMLS CUI

C0209738;

ATC code(s)
- lamivudine [ATC Code]
- lamivudine and dolutegravir [ATC Code]
- lamivudine and raltegravir [ATC Code]
- lamivudine and tenofovir disoproxil [ATC Code]
- lamivudine, abacavir and dolutegravir [ATC Code]
- lamivudine, tenofovir disoproxil and dolutegravir [ATC Code]
- lamivudine, tenofovir disoproxil and doravirine [ATC Code]
- lamivudine, tenofovir disoproxil and efavirenz [ATC Code]
- stavudine and lamivudine [ATC Code]
- stavudine, lamivudine and nevirapine [ATC Code]
- zidovudine, lamivudine and abacavir [ATC Code]
- zidovudine, lamivudine and nevirapine [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analogs and derivatives [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
CISMeF manual mappings
- lamivudine [Substance BNPC]
Currated CISMeF NLP mapping
- Lamivudine [ICD-11 Extension code]
- Lamivudine [SMS substance]
- Lamivudine [NCIt concept]
- Lamivudine (substance) [SNOMED CT concept]
- lamiVUDine [LOINC component]
Pharmacological action(s)
- anti-hiv agents [MeSH Descriptor]
- reverse transcriptase inhibitors [MeSH Descriptor]
Record concept(s)
- BCH-189 [MeSH concept]
- GR-109714X [MeSH concept]
- Lamivudine, (+)-cis- [MeSH concept]
- Lamivudine, (+-)-trans- [MeSH concept]
- epivir [MeSH concept]
- lamivudine [MeSH concept]
- lamivudine, (2S-cis)-Isomer [MeSH concept]
Related MeSH Supplementary Concept(s)
- 2',3'-dideoxy-3'-thiacytidine-5'-monophosphate [MeSH Supplementary Concept]
- N,N-dimethyl-N'-(2',3'-dideoxy-3'-thiacytidine)formamidine [MeSH Supplementary Concept]
- abacavir, dolutegravir, and lamivudine drug combination [MeSH Supplementary Concept]
- abacavir, lamivudine drug combination [MeSH Supplementary Concept]
- abacavir, lamivudine, and zidovudine drug combination [MeSH Supplementary Concept]
- efavirenz, lamivudine, tenofovir disoproxil fumarate drug combination [MeSH Supplementary Concept]
- lamivudine sulfoxide [MeSH Supplementary Concept]
- lamivudine triphosphate [MeSH Supplementary Concept]
- lamivudine, tenofovir disoproxil fumarate drug combination [MeSH Supplementary Concept]
- lamivudine, zidovudine drug combination [MeSH Supplementary Concept]
- lamivudine-PEGylated chitosan [MeSH Supplementary Concept]
- lamivudine-adefovir combination [MeSH Supplementary Concept]
- stavudine, lamivudine, nevirapine drug combination [MeSH Supplementary Concept]
Semantic type(s)
- Nucleic Acid, Nucleoside, or Nucleotide [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Lamivudine [NCIt concept]
- Lamivudine (substance) [SNOMED CT concept]
- Product containing lamivudine (medicinal product) [SNOMED CT concept]
- lamiVUDine [LOINC component]
- lamivudine [ATC Code]
- lamivudine [Substance BNPC]
Validated automatic mappings to BTNT
- lamivudine [ATC Code]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients